Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Volitionrx Ltd as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +4 vs. Q4 2022
- Shares held
- 6.42M
- +221.5K (+3.6%) vs. Q4 2022
- Total value
- $12.2M
- −$2.83M (−18.8%) vs. Q4 2022
- New holders
- 7
- 12 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adirondack Retirement Specialists, Inc. | 32 | $60 | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 100 | $191 | 0.00% | +100 | New |
| Point72 Middle East FZE | 185 | $353 | 0.00% | +185 | New |
| Allworth Financial LP | 200 | $382 | 0.00% | +200 | New |
| BNP Paribas Arbitrage, SA | 265 | $506 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 274 | $523 | 0.00% | +5+1.9% | Added |
| Advisor Group Holdings, Inc. | 520 | $993 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 810 | $1.55K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,000 | $1.91K | 0.00% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 2,265 | $4.33K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,363 | $4.51K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 2,500 | $4.78K | 0.00% | +2,500 | New |
| Credit Agricole S A | 4,000 | $7.64K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 4,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 5,000 | $9.55K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,247 | $12.0K | 0.00% | +1,274+25.6% | Added |
| Sensible Money, LLC | 10,000 | $19.1K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,081 | $19.3K | 0.00% | −3,189−24.0% | Reduced |
| UBS Group AG | 10,106 | $19.3K | 0.00% | +8,180+424.7% | Added |
| Charles Schwab Investment Management Inc | 15,384 | $29.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,318 | $38.8K | 0.00% | −61,637−75.2% | Reduced |
| Bank of New York Mellon Corp | 21,627 | $41.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 26,194 | $50.0K | 0.00% | +26,194 | New |
| Cubist Systematic Strategies, LLC | 30,172 | $57.6K | 0.00% | +30,172 | New |
| JPMorgan Chase & Co | 37,921 | $72.0K | 0.00% | +37,921 | New |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $106.2K | 0.05% | 00.0% | Unchanged |
| Bank of America Corp | 61,000 | $116.5K | 0.00% | +53,066+668.8% | Added |
| Cerity Partners LLC | 65,000 | $124.2K | 0.00% | +26,974+70.9% | Added |
| Northern Trust Corp | 70,092 | $133.9K | 0.00% | +9,245+15.2% | Added |
| Susquehanna International Group, LLP | 112,894 | $215.6K | 0.00% | +64,722+134.4% | Added |
| State Street Corp | 123,923 | $236.7K | 0.00% | 00.0% | Unchanged |
| Cowen Prime Advisors LLC | 181,843 | $309.0K | 0.12% | +4,800+2.7% | Added |
| Bridgeway Capital Management, LLC | 176,100 | $336.4K | 0.01% | +50,000+39.7% | Added |
| Morgan Stanley | 236,503 | $451.7K | 0.00% | −15,393−6.1% | Reduced |
| Geode Capital Management, LLC | 292,726 | $559.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 505,998 | $966.5K | 0.00% | +2,005+0.4% | Added |
| BlackRock Inc. | 547,808 | $1.05M | 0.00% | +6,712+1.2% | Added |
| Lagoda Investment Management, L.P. | 3,775,444 | $7.21M | 5.13% | +20,399+0.5% | Added |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −29,510−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −13,131−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |